Dr Gareth Healey
Senior Lecturer
Medicine
Telephone: (01792) 606474
Room: Meeting Room Enteprise & Innovation - 003
Ground Floor
Institute of Life Science 1
Singleton Campus

Areas of Expertise

  • Nanomedicine
  • Immunology
  • Molecular biology
  • Drug development
  • Project Management
  • Gynaecological cancer
  • Reproductive biology

Publications

  1. & Liquid crystal delivery of ciprofloxacin to treat infections of the female reproductive tract. Biomedical Microdevices 21(2)
  2. & Bovine scavenger receptor class A (SR-A) exhibit specific patterns of regulation in the endometrium during the oestrous cycle and early pregnancy. Reproduction, Fertility and Development
  3. & A RAGE-Targeted Antibody-Drug Conjugate: Surface Plasmon Resonance as a Platform for Accelerating Effective ADC Design and Development. Antibodies 8(1), 7
  4. & Isoprenoids increase bovine endometrial stromal cell tolerance to the cholesterol-dependent cytolysin from Trueperella pyogenes†. Biology of Reproduction
  5. & Maternal metabolism affects endometrial expression of oxidative stress and FOXL2 genes in cattle. PLOS ONE 12(12), e0189942

See more...

Teaching

  • PMNM04 Nanomedicines and Therapeutics

    The module will explore the history and development of molecular medicines. Using landmark technology and chemical development phases, the traditional small chemical entities using in molecular medicine will be outlined, using drugs such as taxols and tamoxifen as exemplars. The common target oncology and non oncology disorders will outlined and their respective targets for such medicines detailed alongside drug modes of action and delivery (IV and oral). Further exploration of targeted nanoparticle delivery, from early first generation drugs such as Abraxane to second generation biologically targeted SMART delivery systems, will expand the knowledge to future molecular medicines such as antibody drug conjugates and kinase inhibitors. Excitingly the module will include guest lectures from industry and clinicians, covering the spectrum of drug development to delivery and clinical considerations.

  • PMNM11 Nanomedicines, pharmaceuticals and advanced therapeutics

    This module will explore the history and development of molecular medicines and pharmaceuticals, providing the basis for an advanced understanding of next generation therapeutic approaches. Using landmark technology and chemical development phases informed by separation science and mass spectrometry, the module uses an application driven approach to provide the student with an extensive knowledgebase of drug development, the pharmaceutical industry and nanotherapeutics. Students will be able to characterize and map the path of a drug from administration, to metabolism and elimination, and critically evaluate drug design and delivery approaches. Traditional small chemical entities used in molecular medicine will be outlined, using drugs such as taxols and tamoxifen as exemplars. Common target oncology and non-oncology disorders will provide the context; with students encouraged to explore targeted nanoparticle fabrication, drug encapsulation and release profiling, from early first generation drugs such as Abraxane to second generation biologically targeted SMART delivery systems. Future molecular medicines such as antibody drug conjugates and kinase inhibitors will be taught by guest lectures from industry and clinicians, covering the spectrum of drug development to delivery and clinical considerations.

Research Groups

  • Reproductive Biology and Gynaecological Oncology

    Reproductive biology and gynaecological oncology research in Swansea covers basic and translational research into: Uterine pathologies, Gynaecological and in vitro fertilisation

Key Grants and Projects

  • CALIN (Celtic Advanced Life Science Innovation Network) 2016

    Project Manager